eXoZymes shareholders elect all six director nominees, approve compensation and 2025 equity plan at annual meeting

EXOZYMES INC.

All six director nominees (Marlett, DiGiandomenico, Bowie, Lalonde, Bell, Rayo) elected with at least 4.25M votes for.
Non-binding advisory resolution on executive compensation approved: 4,272,987 for, 1,801 against.
Shareholders voted for a three-year frequency of future advisory votes on executive compensation (4,121,899 for three years).
2025 Performance Equity Plan approved: 4,181,189 for, 92,840 against.
Ratification of RBSM LLP as auditor for FY2025 received 4,779,589 votes for; quorum was 56.98%.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.